161 related articles for article (PubMed ID: 33208828)
1. Prediagnostic serum 25-hydroxyvitamin D and melanoma risk.
Stenehjem JS; Støer NC; Ghiasvand R; Grimsrud TK; Babigumira R; Rees JR; Nilsen LT; Johnsen B; Thorsby PM; Veierød MB; Robsahm TE
Sci Rep; 2020 Nov; 10(1):20129. PubMed ID: 33208828
[TBL] [Abstract][Full Text] [Related]
2. A protocol for prospective studies of 25-hydroxyvitamin D, leptin and body mass index in relation to cutaneous melanoma incidence and survival.
Stenehjem JS; Grimsrud TK; Rees JR; Vos L; Babigumira R; Veierød MB; Robsahm TE
BMJ Open; 2017 Jun; 7(6):e014829. PubMed ID: 28637727
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and Vitamin D-binding protein and risk of bladder cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort.
Hektoen HH; Robsahm TE; Stenehjem JS; Axcrona K; Babigumira R; Mondul AM; Gislefoss RE; Andreassen BK
Cancer Med; 2021 Jun; 10(12):4107-4116. PubMed ID: 34080787
[TBL] [Abstract][Full Text] [Related]
4. Anthropometric factors and cutaneous melanoma: Prospective data from the population-based Janus Cohort.
Stenehjem JS; Veierød MB; Nilsen LT; Ghiasvand R; Johnsen B; Grimsrud TK; Babigumira R; Rees JR; Robsahm TE
Int J Cancer; 2018 Feb; 142(4):681-690. PubMed ID: 28983909
[TBL] [Abstract][Full Text] [Related]
5. Plasma 25-hydroxyvitamin D and risk of non-melanoma and melanoma skin cancer: a prospective cohort study.
Afzal S; Nordestgaard BG; Bojesen SE
J Invest Dermatol; 2013 Mar; 133(3):629-636. PubMed ID: 23190899
[TBL] [Abstract][Full Text] [Related]
6. In praise of small studies.
Diffey BL
Br J Dermatol; 2011 Jul; 165(1):3-4. PubMed ID: 21707572
[No Abstract] [Full Text] [Related]
7. Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma.
Zigmont V; Garrett A; Peng J; Seweryn M; Rempala GA; Harris R; Holloman C; Gundersen TE; Ahlbom A; Feychting M; Johannesen TB; Grimsrud TK; Schwartzbaum J
Nutr Cancer; 2015; 67(7):1120-30. PubMed ID: 26317248
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness.
Wyatt C; Lucas RM; Hurst C; Kimlin MG
PLoS One; 2015; 10(5):e0126394. PubMed ID: 25970336
[TBL] [Abstract][Full Text] [Related]
9. 25-Hydroxyvitamin D in Patients With Melanoma and Factors Associated With Inadequate Levels.
Hernández-Ostiz S; Pérez-Ramada MD; Ortiz B; Requena C; Ribas G; Aznar E; Nagore E
Actas Dermosifiliogr; 2016 Nov; 107(9):758-764. PubMed ID: 27418183
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
[TBL] [Abstract][Full Text] [Related]
11. Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients.
Nürnberg B; Gräber S; Gärtner B; Geisel J; Pföhler C; Schadendorf D; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3669-74. PubMed ID: 19667163
[TBL] [Abstract][Full Text] [Related]
12. 25-Hydroxyvitamin D serum levels and melanoma risk: a case-control study and evidence synthesis of clinical epidemiological studies.
Cattaruzza MS; Pisani D; Fidanza L; Gandini S; Marmo G; Narcisi A; Bartolazzi A; Carlesimo M
Eur J Cancer Prev; 2019 May; 28(3):203-211. PubMed ID: 29438161
[TBL] [Abstract][Full Text] [Related]
13. Associations of serum 25-hydroxyvitamin D level with incidence of lung cancer and histologic types in Norwegian adults: a case-cohort analysis of the HUNT study.
Sun YQ; Langhammer A; Wu C; Skorpen F; Chen Y; Nilsen TIL; Romundstad PR; Mai XM
Eur J Epidemiol; 2018 Jan; 33(1):67-77. PubMed ID: 29080012
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of 25-hydroxyvitamin D3 Levels at Diagnosis and During Follow-up in Melanoma Patients.
Saiag P; Aegerter P; Vitoux D; Lebbé C; Wolkenstein P; Dupin N; Descamps V; Aractingi S; Funck-Brentano E; Autier P; Dragomir M; Boniol M
J Natl Cancer Inst; 2015 Dec; 107(12):djv264. PubMed ID: 26376687
[TBL] [Abstract][Full Text] [Related]
15. Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort.
Hektoen HH; Gislefoss RE; Stenehjem JS; Langseth H; Axcrona K; Mondul AM; Robsahm TE; Andreassen BK
Clin Epidemiol; 2021; 13():801-811. PubMed ID: 34548821
[TBL] [Abstract][Full Text] [Related]
16. The Impact of UV-dose, Body Surface Area Exposed and Other Factors on Cutaneous Vitamin D Synthesis Measured as Serum 25(OH)D Concentration: Systematic Review and Meta-analysis.
Jager N; Schöpe J; Wagenpfeil S; Bocionek P; Saternus R; Vogt T; Reichrath J
Anticancer Res; 2018 Feb; 38(2):1165-1171. PubMed ID: 29374754
[TBL] [Abstract][Full Text] [Related]
17. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study.
Bilinski K; Boyages J
Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153
[TBL] [Abstract][Full Text] [Related]
18. Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma.
Asgari MM; Tang J; Warton ME; Chren MM; Quesenberry CP; Bikle D; Horst RL; Orentreich N; Vogelman JH; Friedman GD
J Invest Dermatol; 2010 May; 130(5):1438-43. PubMed ID: 20043012
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D and melanoma incidence and mortality.
Berwick M; Erdei EO
Pigment Cell Melanoma Res; 2013 Jan; 26(1):9-15. PubMed ID: 22947439
[TBL] [Abstract][Full Text] [Related]
20. 25-Hydroxyvitamin D status, vitamin D intake, and skin cancer risk: a systematic review and dose-response meta-analysis of prospective studies.
Mahamat-Saleh Y; Aune D; Schlesinger S
Sci Rep; 2020 Aug; 10(1):13151. PubMed ID: 32753685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
